HTA:NYE-Healthcare Trust of America, Inc (USD)

COMMON STOCK | REIT-Healthcare Facilities | NYE

Last Closing Price

USD 28.62

Change

-0.02 (-0.07)%

Market Cap

USD 6.28B

Volume

0.67M

Avg Analyst Target

USD 29.33 (+2.49%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-29 )

Largest Industry Peers for REIT-Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WELL Welltower Inc

+0.34 (+0.39%)

USD36.49B 49.88 35.14
VTR Ventas, Inc

+0.10 (+0.17%)

USD22.39B 54.99 21.19
MPW Medical Properties Trust, Inc

+0.07 (+0.34%)

USD12.21B 22.01 18.53
OHI Omega Healthcare Investors, In..

+0.13 (+0.35%)

USD8.76B 37.35 18.09
HR Healthcare Realty Trust Incorp..

-0.01 (-0.03%)

USD4.47B 47.92 18.27
DOC Physicians Realty Trust

+0.02 (+0.11%)

USD4.06B 57.94 19.97
NHI National Health Investors, Inc

-0.06 (-0.09%)

USD3.13B 19.23 15.53
LTC LTC Properties, Inc

-0.18 (-0.46%)

USD1.53B 33.63 19.23
CHCT Community Healthcare Trust Inc..

+0.48 (+0.97%)

USD1.21B 59.61 26.26
GMRE Global Medical REIT Inc

+0.10 (+0.65%)

USD0.94B 161.88 26.34

ETFs Containing HTA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (REIT-Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.92% 57% F 36% F
Dividend Return 3.49% 79% C+ 80% B-
Total Return 7.41% 57% F 40% F
Trailing 12 Months  
Capital Gain 3.02% 36% F 20% F
Dividend Return 4.61% 36% F 63% D
Total Return 7.63% 36% F 22% F
Trailing 5 Years  
Capital Gain -15.95% 33% F 20% F
Dividend Return 19.09% 27% F 68% D+
Total Return 3.14% 33% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -2.36% 20% F 17% F
Dividend Return 4.51% 40% F 81% B-
Total Return 2.15% 20% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 12.20% 93% A 78% C+
Risk Adjusted Return 17.63% 33% F 27% F
Market Capitalization 6.28B 71% C- 76% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT-Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 110.38 21% F 7% F
Price/Book Ratio 2.00 69% D+ 48% F
Price / Cash Flow Ratio 16.19 50% F 29% F
EV/EBITDA 20.80 46% F 29% F
Management Effectiveness  
Return on Equity 1.75% 29% F 35% F
Return on Invested Capital 2.65% 29% F 41% F
Return on Assets 1.59% 29% F 39% F
Debt to Equity Ratio 95.83% 36% F 39% F
Technical Ratios  
Short Ratio 6.58 8% F 10% F
Short Percent 5.66% 15% F 37% F
Beta 0.61 79% C+ 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.